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Isolation and enumeration of specific cellular subtypes 
from a variety of medically relevant fluids is a core require-
ment in many medical diagnosis and clinical monitoring 
environments. The reduction in number of particular cells 
in the blood of a patient can be diagnostic of a number of 
diseases such as acquired immunodeficiency syndrome 
(AIDS) and hairy cell leukemia.1,2 Conversely, the appear-
ance or elevation of certain cells may indicate progression 
of diseases; for example, there is currently intensive 
research and commercial interest in the detection and enu-
meration of circulating tumor cells in blood samples.3 
Current technologies for such specific cellular monitoring 
(such as flow cytometry) are often large, expensive, and 
require highly trained personnel to operate. Alternatively, 
some bench-based kits are available that minimize the use 
of capital equipment by applying protocols such as chemi-
cal lysing and microscopy to the detection strategy. These 
kit protocols are often labor intensive with a number of 
points where operator intervention is required.
Lab-on-a-chip (LOC) strategies present an attractive 
option for reducing the costs, expertise, and labor time for 
the simplification of cellular monitoring devices in medical 
fields,4 and there is a growing number of companies with 
commercialized instruments either on the market or in the 
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Abstract
In medical diagnostics, detection of cells exhibiting specific phenotypes constitutes a paramount challenge. Detection 
technology must ensure efficient isolation of (often rare) targets while eliminating nontarget background cells. Technologies 
exist for such investigations, but many require high levels of expertise, expense, and multistep protocols. Increasing 
automation, miniaturization, and availability of such technologies is an aim of microfluidic lab-on-a-chip strategies. To this 
end, we present an integrated, dual-force cellular separation strategy using centrifugo-magnetophoresis. Whole blood 
spiked with target cells is incubated with (super-)paramagnetic microparticles that specifically bind phenotypic markers on 
target cells. Under rotation, all cells sediment into a chamber located opposite a co-rotating magnet. Unbound cells follow 
the radial vector, but under the additional attraction of the lateral magnetic field, bead-bound target cells are deflected to 
a designated reservoir. This multiforce separation is continuous and low loss. We demonstrate separation efficiently up to 
92% for cells expressing the HIV/AIDS relevant epitope (CD4) from whole blood. Such highly selective separation systems 
may be deployed for accurate diagnostic cell isolations from biological samples such as blood. Furthermore, this high 
efficiency is delivered in a cheap and simple device, thus making it an attractive option for future deployment in resource-
limited settings.
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final stages of testing that are using these technologies for 
cell monitoring.5,6 Such strategies shift the focus of a tech-
nology from highly expensive machinery with simple con-
sumables to a small and low-cost detection device using 
highly engineered but cheaply manufactured consumables.5 
These devices often require operator intervention simply to 
add a sample to the diagnostic cartridge and insert the car-
tridge into an instrument. Fully automated fluid handling 
and other functions are then carried out within the system. 
Instead of a major investment in capital machinery that may 
overshoot the intended purpose, the LOC option places 
such diagnostics within the price range of most facilities, 
with minimal cost of ownership mainly constituted by the 
consumables (i.e., microfluidic chips). In addition, such 
instruments and chips are very specific in their purpose and 
so eliminate increased costs associated with unnecessary 
functionality that is often associated with capital equip-
ment. A prime goal of developing such LOC strategies is to 
adapt the technology into point-of-care (POC) devices 
enabling deployment of cell-based medical monitoring to 
the site of high patient density, rather than shipping patient 
samples to (often remote) central laboratories. Deployment 
of POC devices has already been shown to positively influ-
ence the retention of patients in disease-monitoring pro-
grams in resource-poor settings.7 The application of LOC 
and automation to HIV/AIDS POC diagnostics in resource-
poor regions is a model for the validity of matching a par-
ticular technology to a specifically relevant societal need. 
HIV diagnostic devices employing LOC strategies have 
seen medical and commercial success since 2009 and have 
been extensively reviewed recently.8,9
A number of research groups have developed LOC tech-
niques and devices enabling the purification of specific 
phenotypes from biological backgrounds. Many of these 
devices have made use of paramagnetic beads to bind cells 
in a mobile phase and subsequently relocate them to detec-
tors or areas on a chip where they can be manually enumer-
ated.10–13 Often, the passage of sample in these devices has 
been driven by capillary flow. In the work presented here, 
we build on previous work carried out in this group in which 
the LOC strategy is integrated into a spinning platform, 
allowing rapid movement of sample through microfluidic 
structures and an increase in throughput by placing a num-
ber of such structures on a single, DVD-sized disc. This is 
the so-called “lab-on-a-disc” strategy.14,15
In an endeavor to develop a compact, user-friendly, and 
cost-efficient sample-to-answer device for highly accurate 
target cell counts, we introduce here a novel method for 
centrifugo-magnetophoretic cell separation that is amena-
ble to complete integration into a lab-on-a-disc platform.14,16 
As a proof-of-concept and an intermediate step, this work 
implements a bead-based immunomagnetic isolation of 
cells expressing the CD4 antigen on the cell surface—CD4-
expressing cells being the primary host cell of the HIV virus 
and hence of prime diagnostic relevance. This work aims to 
demonstrate efficiency of cell capture as well as recovery of 
CD4-positive cells spiked into a fresh blood sample 
extracted via finger-prick lancets. Our separation is based 
on a recently developed centrifugo-magnetic platform for 
bead-based assays, which showed a 96% separation effi-
ciency of biomimetic magnetic beads from a background of 
thousands of particles.17 Although other multiforce centrif-
ugal strategies have been used to separate cells (such as cen-
trifugal forces combined with a dielectrophoretic force18), 
here we use a centrifugal force combined with a magnetic 
force that can be integrated onto the disk at very low cost, 
and additionally we target a specific cellular phenotype for 
isolation.
Operational Principle
Centrifugo-magnetic particle separation (Fig. 1) has so far 
been demonstrated using polystyrene beads in a magnetic 
field created by three co-rotating magnets (M1 to M3).17 
For the cell separations presented in this article, the outer 
magnets at positions M1 and M3 were removed, as it was 
found that a single magnet at M2 was optimum for the pur-
pose of separating magnetically tagged CD4 cells from 
whole blood (Figs. 1 and 2). Samples are pipetted into the 
loading chamber (Fig. 1ii), and when the disc is spinning, 
cells and particles enter the focusing channel, where they 
are aligned along the wall distant to the magnet. Upon leav-
ing the focusing channel, nonmagnetic particles (i.e., blood 
and/or spiked cells that do not bind to magnetic beads) sedi-
ment on straight, radial trajectories through the separation 
chamber directly into capture finger B, which is most dis-
tant from the magnet (referred to in the text as the “waste” 
chamber). In contrast, unbound magnetic beads are strongly 
deflected toward the permanent magnet located near the 
sidewall of the separation chamber at the M2 position. 
Finally, the subpopulation of magnetically tagged CD4 tar-
get cells that display a large magnetic moment and experi-
ence a large centrifugal force travel on an intermediate, 
moderately curved trajectory to capture area C, referred to 
in the text as the “capture” chamber (Fig. 1). On completion 
of a successful experiment, there are hence three destination 
regions in the structure. Position A is occupied by unbound 
excess magnetic beads. Position B (“waste”) is populated 
by a mixed population of background material and nonse-
lected spiked cells, for example, blood and/or HeLa cells in 
the current experiments. This mixed population will be 
depleted of the particular cell type to which the experimen-
tal magnetic beads are bound. Position C (“capture”) will 
then be the locus to which the cells depleted from position 
B will be resolved. This means that the cells of interest will 
be positively selected and ultimately directed to the capture 
chamber, leaving a depleted mix of background material in 
the waste chamber.
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A key aspect of the separation performance mentioned 
here is the stopped-flow or batch mode characteristic (i.e., 
as in a regular centrifuge); there is no flow of liquid in the 
rotating system. Therefore, particles (i.e., cells or magnetic 
beads) will merely sediment through the residual priming 
medium in the chamber (in the disc frame). This is in con-
trast to common microfluidic systems in which liquid flow 
conveys the suspended particles by virtue of the Stokes 
drag.19–21 These flow-based systems exhibit parabolic flow 
profiles and are prone to hydrodynamic instabilities and 
divergent flow around objects. By using a stopped-flow 
scheme, cells and particles in our structure will experience 
only the centrifugal and magnetic forces, as well as the 
velocity-dependent Stokes drag of the surrounding medium. 
This results in the sample acting as a collection of individ-
ual particles (i.e., blood cells) rather than a fluid. This strat-
egy is integral to extracting the target particles of interest.
The separation of intrinsically nonmagnetic target cells 
from a mixed background population using magnetic beads 
is quite complex as the extent of deflection depends on the 
individual load of the attached magnetic tags. The amount 
of binding is, for instance, governed by the concentration of 
the magnetic beads, the amount of receptors expressed on 
the cell surface, the buffer composition, and the bead/sam-
ple incubation procedure.
Modeling of Particle Trajectories
To acquire an understanding of how the various particles in 
this system would behave and what forces would be neces-
sary to achieve the best separation, theoretical calculations 
were carried out.
The particle trajectories are governed by the centrifugal 
force
F mrω = ω
2 ,
 (1)
where m is the particle mass, r is the radial distance from 
the center of rotation, and ω2 is the angular frequency of 
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where χP and χM are the magnetic susceptibilities of the par-
ticle and the medium, respectively, VP is the volume of the 
particle, µ0 is the magnetic permeability of the liquid, and B 
is the local magnetic field strength. The Stokes drag follows 
the equation
F R vD = 6 0π η ,  (3)
where η is the viscosity of the liquid, R0 is the radius, and ν 
is the velocity of the particle.
Unbound cells (i.e., red blood cells) will experience only 
the radial centrifugal force and the frictional Stokes drag 
pointing opposite to the direction of their migration through 
the stagnant liquid. All magnetic particles, whether unbound 
or attached to target cells, will, in addition, be exposed to 
the (local) magnetic force, which acts essentially perpen-
dicular to the radial direction. Managing the balance of 
these three forces on each of the three particle species in 
Figure 1. (i) Three-dimensional (3D) rendering of the lab-
on-a-disc. The disc consists of a bottom layer of PMMA and a 
top layer of polydimethylsiloxane containing the microfluidic 
channels (green) and the co-rotating magnets (gray). For the 
experiments described, magnets were installed in only the M2 
positions. The center of rotation is indicated by a dashed line, 
and the direction of rotation is indicated by an arrow. The 
depth of the chambers is 100 µm, and the width of the focusing 
chamber is also 100 µm. (ii) Photograph of one of the six on-
disc microfluidic chambers with relevant features labeled: A, 
site of unbound bead collection; B, chamber for collection of 
undeflected, i.e., nonmagnetically tagged cells (“waste” chamber); 
C, chamber for collection of deflected, i.e., magnetic bead-
bound cells (“capture” chamber). In the work presented here, 
the permanent magnets at M1 and M3 have been removed. (iii) 
Schematic of same chamber with magnetic field lines generated 
only by M2. Estimated strength of the magnetic field indicated at 
points (*1–3). Centrifugal force indicated by the arrow marked 
Fω, and magnetic force indicated with the arrow marked Fm.
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question, mainly by means of the spinning frequency ω, the 
chamber geometry, and the alignment of the magnet(s), is 
pivotal to the sorting of tagged cells from such a complex 
background.
Another rotationally induced force, the Coriolis force, is 
notably smaller than the other forces. However, the Coriolis 
force may still affect the predominantly radial travel of non-
magnetic cells. The Coriolis force acts in the plane of the 
disc, perpendicular to the motion of the particle and oppo-
site to the direction of rotation. Therefore, the direction of 
rotation was chosen to ensure the Coriolis force acts to 
drive the nonmagnetic (background) cells away from the 
magnets and help focus the flow of these cells into a narrow 
stream against the wall of the chamber.
Materials and Methods
Disc Fabrication and Priming
The microfluidic discs used in this system were formed 
from a silicone elastomer; polydimethylsiloxane (PDMS; 
Dow Corning, MI) mixed at a ratio of 5:1 base and curing 
agent. The procedure for making a master has been 
described in detail elsewhere.17,22 As the cavities for secur-
ing the co-rotating magnets in the PDMS were too large to 
be formed by the lithography master (5 mm in height), a 
polymer mold was printed on an uPrint SE 3D printer 
(Stratasys, MN). This mold consisted of a large, disclike 
structure with appropriately sized posts descending to the 
silicone base. The mold was held in place during the PDMS 
curing process by guide pins. These pins also allowed align-
ment of the mold to be reproduced for multiple discs. When 
the PDMS was poured, it formed both the lithographic 
structures of the microchannels and also the large cavities 
for the magnets.
Once the magnet-positioning mold was aligned above 
the silicon master, 26 g of PDMS was poured into the mold 
and cured in an oven at 70 °C for 40 min. The PDMS was 
cut out and pealed from the wafer, leaving the microfluidic 
structures on the underside and cavities for placing the mag-
nets through the PDMS. Sample-loading holes and vents 
were defined in the PDMS at appropriate locations using a 
Figure 2. Centrifugo-magnetophoretic distribution of homogenous, i.e., single-phenotype, cultured human cell populations. (i) 
Fluorescent images of either HL60 (left) or HeLa (right) cells imaged following centrifugo-magnetophoresis with optimized spin speeds 
and time. White dashed lines represent edges of the chambers as seen in differential interference contrast (DIC). Scale bars are 100 
µm. (Note scale difference between capture and waste chambers.) (ii) Bar charts were generated based on the RawIntDen values 
measured in both chambers and represent the relative distribution of fluorescence between capture and waste chambers. Error bars 
indicate one standard deviation.
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dot punch. Finally, the PDMS was mounted to a PMMA 
base. This has been described previously.17 Both the depth 
of the chamber and the width of the focusing channel on the 
fully assembled disc measured 100 µm.
To prime the microchannels and structures, the disc was 
placed under vacuum for at least 1 h, following which a 
large drop of priming buffer (phosphate-buffered saline 
[PBS] pH 7.4, 0.1% w/v bovine serum albumin [BSA], 1 
mM EDTA) was immediately placed on the surface of the 
PDMS, covering both the sample ports of the loading cham-
ber. Degas driven flow then primes the channels.23 Magnets 
used were NdFeB N45 cylindrical magnets, with a diameter 
of 3 mm and a height of 6 mm (Supermagnete, Germany). 
Magnets were placed in the molded cavities before the sam-
ples were loaded to the disc.
The stopped-flow characteristic arises from priming the 
dead-end chamber to its maximum volume capacity. In a 
second step, a sample volume is introduced to the chamber 
by displacing the same volume of priming buffer out of the 
second port into the sample input region.
The magnetic field strength in the centrifugo-magneto-
phoretic chamber was estimated using the finite element 
method magnetics software package (FEMM v4.2).24
Blood Extraction and Cell Culture
Blood was extracted directly from healthy donors via finger 
prick using 1.5 mm sterile lancets (BD Biosciences, 
Franklin Lakes, NJ). To prevent coagulation of the blood 
sample, 60 mM EDTA solution was immediately added to 
the sample to result in a final concentration of 6 mM EDTA 
in the whole blood. The whole blood/EDTA sample was 
then further diluted 1:3 in blood dilution buffer (100 mM 
PBS, pH 7.4, 0.05 mM EDTA). Blood was isolated and pre-
pared fresh, directly before experimental use.
Where indicated, white blood cells (WBCs) were 
extracted from whole blood using standard-density gradient 
separation with Ficoll-Paque 1077 (Sigma-Aldrich, St. 
Louis, MO). Briefly, extracted blood was diluted 1:3 in 
blood dilution buffer and carefully layered over Ficoll-
Paque in a 15 mL conical tube. Following a 300g, 15-min 
spin in a swing-out bucket centrifuge (Hettich Zentrifugen, 
Germany), the WBC-containing “buffy coat” layer was iso-
lated and resuspended in blood dilution buffer. When appro-
priate, cultured cells were spiked into whole blood or WBC 
samples as indicated.
All cell culture reagents were obtained from Sigma-
Aldrich unless otherwise stated. HeLa and HL60 cells (both 
from DSMZ, Braunschweig, Germany) were cultured in 75 
cm2 flasks in DMEM or RPMI 1640 media, respectively, 
with 10% uninactivated fetal bovine serum, 100 U/mL peni-
cillin, and 100 µg/mL streptomycin. Cultures were main-
tained at 37 °C with 5% CO2. Harvesting of HeLa cells was 
carried out by incubation in 5 mL 0.25% trypsin/0.1% 
EDTA at 37 °C for 5 min followed by neutralization with 5 
mL DMEM culture medium. Cells were centrifuged at 300g 
for 4 min and resuspended in DMEM culture media. HL60 
cells were harvested by removing a volume of culture, cen-
trifuging as above, and resuspension in RPMI 1640 culture 
media.
Where indicated, live cells were fluorescently stained 
with either NucBlue Live Cell Stain or 5nM Syto64 (both 
from Life Technologies, Carlsbad, CA) according to the 
manufacturer’s instructions.
Dynabead CD4 Sample Incubation
Experimental samples composed of homogenous cell cul-
tures (HeLa or HL60), mixed cell cultures (HeLa and 
HL60), or blood spiked with either homogenous or mixed 
cultures were treated with Dynabeads CD4 magnetic beads 
(Life Technologies). Incubations were carried out in a 2 mL 
Eppendorf tube, and final incubation volume was 200 µL 
per sample, composed of 140 µL incubation buffer (PBS pH 
7.4, 0.1% w/v BSA, 1 mM EDTA), 50 µL experimental 
sample, and 10 µL Dynabead CD4. In the sample as 
described, the beads are present at a final concentration of 
about 1 × 104 µl–1. A double layer of Parafilm (Pechiney 
Plastic Packaging Company, Chicago, IL) was placed 
between the cap and the tube, and incubation was performed 
at room temperature with rotation for 10 min. Three micro-
liters of Dynabead CD4–treated sample was introduced to 
the loading chamber of the disc via pipetting. Where indi-
cated, the incubation time was reduced.
Discs were spun on a custom-built test stand composed 
of a Cool Muscle CM2-X-56B10A motor (Muscle Corp, 
Osaka, Japan) with a custom chuck that was machined for 
securely attaching standard discs to the servo-motor shaft. A 
desktop PC (Dell, Round Rock, TX) was used to control the 
spin-speed of the motor.
Microscopic Imaging and Quantification of Signal
Following spin cycles on the test stands, fluorescently 
stained cells were visualized on disc using an Olympus 
IX81 inverted epifluorescent microscope (Olympus, Tokyo, 
Japan). Because of similar excitation and emission fluores-
cence profiles, NucBlue- and Syto64-stained cells were 
visualized using a DAPI or TexasRed filter set, respectively. 
Unstained cells were visualized using differential interfer-
ence contrast (DIC) on the same microscope. Relative dis-
tribution of fluorescent signal between the waste (B) and 
capture (C) structures of the disc were calculated as follows 
using the ImageJ software package (National Institutes of 
Health, Bethesda, MD).25 For a given experiment, the over-
all cell coverage was observed in both the capture and 
waste, and the chamber containing the largest zone of cell-
occupied area was selected. A region of interest (ROI) was 
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generated using a DIC image that encompassed all cells 
present in the selected chamber, and the area of this ROI 
was calculated. A second ROI was then generated on the 
partner chamber and was reshaped to encompass the cham-
ber itself with minimal coverage of the surrounding PDMS. 
Importantly, this second ROI was given dimensions to 
result in identical overall area to the first ROI. These ROIs 
were then applied to the corresponding fluorescent images 
for each chamber, and the raw integrated density values 
(“RawIntDen” measurement in ImageJ) of the ROIs were 
measured. RawIntDen values were also measured in identi-
cally sized and shaped ROIs placed on cell-free regions of 
the chambers to generate background signal values, which 
were subtracted from the values generated from the cell-
containing ROIs (Fig. 3).
Relative distribution of fluorescent signal was then cal-
culated using the following:
Experimental Results
Specificity of Dynabead CD4 Magnetic Bead 
Binding
The specificity of the Dynabeads CD4 reagent was first 
demonstrated within our particular experimental condi-
tions. Both HL60 (CD4 positive) and HeLa (CD4 negative) 
cells were independently stained with NucBlue and Syto64, 
respectively. Equal numbers of each cell type (1 × 105 ml–1) 
were then mixed and incubated with the Dynabead CD4 
reagent as described above. An 8 µL aliquot of the incu-
bated sample was deposited on a microscope slide and a 
coverslip placed on top of the sample. Cells were imaged as 
described. A blue color was applied to fluorescence detected 
in the DAPI channel, and a green color was applied to fluo-
rescence detected in the TexasRed channel; ImageJ was 
then used to merge the channels into a single image.
In all fields that were viewed, the Dynabeads were found 
co-localizing only with HL60 (colored blue in Fig. 4) and 
never with HeLa (colored green in Fig. 4), thus demonstrat-
ing a high binding specificity of the Dynabeads for CD4 
Figure 3. Calculation of relative distribution of fluorescence 
between capture and waste chambers. Differential interference 
contrast images of the capture chamber were used to draw 
a signal region of interest (ROI) encompassing the cell/bead 
occupied area in the chamber (yellow hatched box). An identical 
background ROI was then placed on a non–cell/bead occupied 
area of the same chamber to measure the level of background 
fluorescent signal in the chamber (red hatched box). The area of 
the signal ROI was calculated, and both signal and background 
ROIs with identical area were drawn on the waste chamber, 
encompassing the cell/bead occupied and nonoccupied areas, 
respectively. All ROIs were then applied to the fluorescent 
images, and RawIntDen values were measured. The values of 
the background ROIs were subtracted from the relevant signal 
ROI for each chamber. Note: In the shown example, the cell/
bead occupied area of the capture chamber was observed to be 
the larger of the two chambers and hence the benchmark for 





Figure 4. Specificity of Dynabead CD4. Fluorescence image 
of HL60 (blue, CD4 positive) and HeLa (green, CD4 negative) 
following incubation of a mixed sample with Dynabeads CD4 
magnetic beads. Scale bars are 10 µm.
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positive cells under the experimental conditions used 
throughout this work. Furthermore, the average number of 
Dynabeads binding to a single HL60 cell was about 4 (data 
not shown).
Centrifugo-magnetophoretic Routing of 
Homogenous Cell Populations
To calibrate the settings of the spin stand to achieve the 
optimal balance between magnetic and radial forces that 
segregate CD4-positive cells to the capture chamber while 
ensuring that CD4-negative cells maintain their trajectory 
along the radial axis to the waste chamber, initial experi-
ments were performed using homogenous cultures of either 
CD4-positive HL60 or CD4-negative HeLa cells. Equal 
numbers of cells from each cell line (1 × 106 ml–1) were 
independently stained with NucBlue, incubated with the 
Dynabead CD4 reagent, and processed by centrifugo-mag-
netophoresis as described. As neither the strength nor the 
position of the permanent magnet is adjustable on the disc, 
the variable factor that can be controlled to achieve optimal 
magnetic/radial force balance is the rotor speed. It is also 
possible to adjust this balance by altering the viscosity of 
the priming buffer or the size of the magnetic beads; how-
ever, for the current experiments, only the rotor speed was 
examined as this can be rapidly adjusted in real time along 
the experiment. Following completion of the spin cycle, the 
disc was visualized on an IX81 Olympus epifluorescent 
microscope. Images were taken at the capture, waste, and 
M2 positions for all experiments, and relative distribution 
of fluorescence was calculated as described.
The optimal spin speed for the centrifugo-magnetopho-
retic disc to segregate the homogenous cells to the distribu-
tions shown in Figure 2 was found to be 10 Hz (RCF = 18 
× g). At this speed, the discs were spun for 40 min to allow 
the majority of the sample to exit the loading chamber and 
progress to the capture and/or waste chambers. In most 
cases, a small percentage of the experimental sample would 
remain in the loading chamber, and increased centrifugal 
force or time would not promote these cells into the segre-
gation chamber. These “stalled” cells may result from their 
binding to the PDMS in the chamber. A BSA concentration 
of 0.1% in the priming solution minimized the proportion of 
such stalled cells. Although at slower spin speeds (about 
5–7 Hz) the efficiency of capture was not adversely affected, 
the time required to resolve the cells to their relevant cham-
bers increased to 60 min, and a number of the target cells 
were captured at the M2 magnetic position rather than the 
capture chamber. This is due to the increased relative mag-
netic force relative to the centrifugal force. Conversely, 
with spin speeds in excess of 12 Hz, an increasing number 
of target cells resolved to the waste chamber, as the radial 
force was increased sufficiently to overcome the lateral 
magnetic force and hence prevent a number of cells from 
deflecting from the radial trajectory. The final combination 
of 10 Hz for 40 min gave the most favorable combination of 
sensitivity (CD4-positive cells to capture), specificity 
(CD4-negative cells to waste), and time to completion.
Under the above-defined conditions, and using samples 
composed of homogenous cell cultures, the current structure 
achieved a balance between magnetic and radial centrifugal 
forces that efficiently directed >99% of HL60 cells to the 
capture chamber while guiding CD4-negative HeLa cells to 
the waste chamber. A small number of HL60 cells were 
guided to the waste chamber. This may be attributed to a 
lower efficiency of Dynabead binding to these cells during 
incubation, either due to steric hindrance from other cells or 
to a small subpopulation of HL60 cells expressing lower 
CD4 levels. Similarly, a small number of HeLa cells were 
directed to the capture chamber. Higher magnification of 
these cells did not show any visible co-localizing Dynabeads, 
suggesting this low level of nonspecific capture is not due to 
bead interaction but due to other factors such as cell-cell 
binding. In the case of both HL60 and HeLa, unbound 
Dynabeads were captured at the M2 position of the chamber. 
As expected, the area occupied by unbound beads in the 
HeLa experiments was larger than that observed in the HL60 
experiments as the beads were not sequestered by cells.
The Dynabeads CD4 reagent used in these experiments 
can also be supplied as part of a kit (T4 Quant Kit, Life 
Technologies). This kit allows bench-based CD4 enumera-
tion from a blood sample of a diagnostic quality but without 
the use of capital equipment other than standard laboratory 
apparatus (pipettes, disposable tubes, etc.) and a fluorescent 
microscope. The 10 min off-disc incubation step to mix 
cells with beads (see the “Materials and Methods” section) 
was selected as it is a required step when using the T4 Quant 
kit. However, as the experimental sample volume that will 
be exposed to magnetic isolation is significantly lower in 
the centrifugo-magnetophoresis strategy (3 µL compared 
with 425 µL), experiments reducing or eliminating the incu-
bation step on the disc-based system were carried out on 
HL60 cells (Table 1).
When processed on a centrifugo-magnetophoresis sys-
tem, the requirement for the incubation step is reduced. 
Although there is a downward trend as the incubation time 
Table 1. Summary of fluorescence distributions with reduced 
off-disc incubation times.
Reduced Cell/Bead Off-Disc Incubation  
Time (% Fluorescence Distribution)
 10 min 1 min 0 min
Capture 99.2 ± 1.1 94.9 ± 3.7 89.1 ± 2.7
Waste 0.8 ± 1.1 5.1 ± 3.7 10.9 ± 2.7
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reduces, when it is eliminated entirely, about 90% of the 
target cells are still captured. In an advancement of the 
experiments shown in Figure 2, we demonstrated that when 
HL60 and HeLa cells are mixed into a heterogeneous popu-
lation, the centrifugo-magnetophoresis system can separate 
the HL60 cells from the background HeLa with high effi-
ciency (Supplementary Information S1).
Centrifugo-magnetophoretic Isolation of CD4-
Positive Cells from Blood
The ability to purify (or otherwise identify) cells of interest 
from a background of similar but interfering materials is of 
primary concern for cell detection technologies.20,26,27 This 
is of particular importance in medical settings, where type I 
or type II errors (false-positive and false-negative, respec-
tively) can lead to misdiagnosis of presenting patients, thus 
resulting in increased costs and patient distress due to 
unnecessary therapies or delayed initiation of treatment.6 
Although the previously introduced segregation of two cell 
lines with distinct phenotypes in buffer medium is of inter-
est predominantly to the research community, the investiga-
tion of complex fluids such as whole blood is of paramount 
medical and commercial significance. Lab-on-a-disc strate-
gies have been used in the isolation of macro-fractions of 
blood such as the hematocrit and plasma.28–30 To further 
advance the disc strategy, demonstrating that specific cel-
lular phenotypes can also be isolated from medically rele-
vant backgrounds on these systems yet still maintain the 
amenability to low-cost manufacture and minimal complex-
ity in an associated apparatus is an advantage of lab-on-a-
disc and of interest to industrial developers.5 To this end, we 
examined the ability of our system to isolate the CD4 cel-
lular phenotype from a background of whole blood. To fur-
ther validate the potential application of the current platform 
for cheap and robust medical diagnosis, operator-derived 
finger-prick capillary blood was used rather than intrave-
nous blood, which must be extracted by a trained medical 
practitioner.
These experiments were examined in two stages. 
Initially, the efficiency of the system for isolating a homog-
enous, CD4-positive cell population from blood was inves-
tigated, followed by experiments in which dual staining was 
used to investigate the level of contaminating CD4-negative 
cells copurifying with the HL60 cells when isolated from 
the blood background. Whole blood was extracted from 
healthy donors and processed for anticoagulation as 
described. In the case of the homogenous cell experiments, 
stained HL60 or HeLa cultures were spiked to blood. For 
the mixed cell experiments, HL60 cells were stained with 
NucBlue, and HeLa cells were stained with Syto64. Cells 
were washed to prevent nonspecific staining, and then ali-
quots were spiked to the same blood sample, which was 
immediately followed by Dynabead CD4 incubation and 
centrifugo-magnetophoresis at 10 Hz for 40 min. Cultured 
cells were spiked into the blood at a concentration of 1 × 105 
ml–1. ImageJ was used to merge the fluorescent channels 
with DIC into a single image.
Because of the significantly increased complexity of the 
matrix, the resolution was expected to fall short of the 
experiments using only cultured cells (Fig. 2; Suppl. Fig. 
S1). Yet the centrifugo-magnetophoretic lab-on-a-disc plat-
form demonstrates an efficient isolation of target CD4-
positive cells from a complex biological background 
sample. In the case in which a homogenous population was 
present in whole blood, more than 90% of HL60 cells were 
resolved to the capture chamber whereas the blood material 
resolved to the waste (Fig. 5i). In the parallel experiment, 
CD4-negative HeLa cells were resolved almost entirely to 
the waste chamber along with the blood, leaving the capture 
chamber essentially empty (Fig. 5i). Unbound Dynabeads 
were captured at the M2 position, with a larger mass of 
beads present in the experiments using CD4-negative cells 
(data not shown). When challenged with a dual population 
of spiked cells in the blood sample (representing two dis-
tinct cellular phenotypes), our separation system achieved 
>80% capture of the CD4-positive cells, whereas about 
10% of the nontarget cells were co-isolated with the cells of 
interest. The lower efficiency of separation compared with 
the homogenous cell experiments may represent a phenom-
enon in which cell-cell interactions and immunocomplex 
formation may capture nontarget cells in macro-cellular 
complexes along with the positively selected population. 
Interestingly, the efficiency of HL60 capture is similar 
between Supplemental Figure S1 (85.2%) and Figure 5ii 
(83.7%), experiments representing co-incubation of both 
phenotypes in the absence and presence of blood, respec-
tively. This would suggest that the presence of blood did not 
have a notable effect on the efficiency of separation and that 
the reduction of separation efficiency for cell line experi-
ments is merely an artifact related to cell culture. As the 
efficiency of HL60 isolation from blood in the absence of 
HeLa is higher (92.0%; Fig. 5i), this supports the notion 
that the reduction in efficiency is due to the cultured and 
spiked nature of the target cells and may not be representa-
tive of the native wild-type CD4 population in the blood. 
Further experiments focusing on the isolation of native 
CD4 Th cells from blood are ongoing.
To investigate whether the concentration of spiked cul-
tured cells had an effect on the efficiency of the system, 
further experiments were carried out in which 5 × 104 ml–1 
and 2 × 105 ml–1 HL60 cells were spiked to the blood. These 
represent 0.5× and 2× concentrations, respectively, of 
spiked cells relative to that shown in Figure 5. Isolation in 
these experiments showed efficiencies of 93.0% ± 1.4% and 
94.0% ± 4.2%, respectively, indicating that (within the 
ranges tested) the concentration of spiked cells did not sig-
nificantly alter the efficiency of isolation.
Glynn et al. 293
Many of the medically relevant cellular blood assays are 
concerned only with the WBC population in a sample, and 
parallel work carried out in the research group has focused 
on the applications of on-disc buffy coat extraction as a 
means of reducing the overall volume of a whole-blood 
sample that must run through the microfluidic structures of 
a POC device. To investigate if the current centrifugo- 
magnetophoretic lab-on-a-disc device will isolate cells of 
Figure 5. Centrifugo-magnetophoretic distribution of CD4-positive and/or CD4-negative cells from a whole blood background. 
(i) Whole capillary blood derived from finger-prick lancet extraction spiked with homogenous stained cultures of either HL60 (left) 
or HeLa (right) was processed by centrifugo-magnetophoresis. (ii) A heterogeneous sample of NucBlue stained HL60 and Syto64 
stained HeLa cells was spiked into a single whole capillary blood sample and processed by centrifugo-magnetophoresis. In all images, 
HL60-derived fluorescence is assigned a blue color, and HeLa-derived fluorescence is assigned a green color for clarity. Differential 
interference contrast (DIC) microscopy was used to visualize the blood sample (seen in the waste chamber). The dark regions in the 
capture chamber seen in DIC represent the cell-bound beads, with some bead clusters that escaped capture at M2. Bar charts were 
generated based on the RawIntDen values measured in both chambers and represent the relative distribution of fluorescence between 
capture and waste chambers. Error bars indicate one standard deviation. Scale bars are 100 µm.
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interest from such a background sample, stained cells were 
spiked into a blood sample, and then a standard off-disc 
Ficoll-Paque buffy coat band extraction protocol was per-
formed. The resulting sample (composed of native WBC 
and the spiked cells) was then incubated with Dynabead 
CD4, spun, and visualized as described above. Results of 
these experiments are included in Table 2 and showed 
>90% efficient isolation of the spiked CD4-expressing 
HL60 cells, very similar to the results generated using 
whole blood. Table 3 sums up the data pertaining to mixed 
cell populations from all experiments. Cell lines underlined 
represent the line in the experiment that was quantified.
Conclusions and Outlook
Coupled with molecular medicine, access to reliable and 
accurate cellular diagnosis technologies is rapidly becoming 
a major determinant of improving the prognosis of patients 
inflicted with various metabolic and infectious illnesses.2,31–33 
In the case of cellular diagnosis, the hardware and expert 
personnel required to deploy the technologies have been 
restrictive in delivering rapid sample-to-answer results to a 
patient; furthermore, the cost factor has largely limited the 
technology to high-income regions. Because of its inherent 
portability and relatively simple manufacture, the applica-
tion of lab-on-a-chip technologies to cellular diagnostic 
applications has the potential to be a turning point in deliver-
ing affordable medical intervention to the bedside.5 However, 
to be a viable option, the accuracy of such devices should be 
on a par with flow cytometry, the current gold standard in 
cellular analysis. Of critical importance to the development 
of such technology is the reliable on-chip isolation of rele-
vant cells from a complex biological background. Previous 
work in our group has demonstrated the ability of a lab-on-
a-disc centrifugo-magnetophoretic platform to efficiently 
separate a population of rather monodisperse magnetic 
beads from a background of other beads.17 In our 
work presented here, we for the first time demonstrated a 
significant advancement of this system leveraging highly 
efficient biological applications by enabling target cell isola-
tion from a complex biological background based on spe-
cific cell- 
surface phenotypes. Furthermore, for cell isolation, the only 
hardware required is a speed-controlled spinning motor with 
a low-cost, reusable, on-disc magnet.
The system positively isolates a specific cellular pheno-
type of interest and deposits it to a reservoir that may be 
linked to structures that could further process the isolate to 
generate an on-disc indication of concentration. We used the 
system to specifically target and isolate cells expressing the 
HIV/AIDS-relevant CD4 epitope, a cell surface marker nor-
mally expressed on T-helper lymphocytes in whole blood. 
Based on the fluorescence distribution between the capture 
and waste structures of the chamber, the efficiency of the sys-
tem consistently demonstrated >85% isolation of cells when 
samples of CD4-positive cells were mixed with a sample of 
background CD4-negative cells. When this cellular mix was 
placed into a sample of whole blood, the efficiency of CD4-
positive isolation was essentially maintained, suggesting that 
medically relevant samples will not pose a further significant 
challenge to the ability of this system to successfully isolate 
cells of interest. Importantly, the experiments presented in 
this work used cultured human cells spiked into a blood sam-
ple to demonstrate the proficiency of the system. Such cells 
often tend to generate cell-to-cell interactions resulting in 
binding and clumping,34 which in the case of the experiments 
shown here may have reduced the perceived efficiency of the 
system. Indeed, when CD4-positive cultured cells alone (i.e., 
CD4-negative HeLa cells were absent) were introduced into 
a blood sample and processed on the centrifugo-magneto-
phoretic system, the efficiency of purification was increased 
from 83.7% to 92.0%. We are hopeful that this is an indica-
tion that the efficiency of the system may be further increased 
when there are no spiked cultured cells present in a sample at 
all, and only native wild-type CD4 T-helper lymphocytes are 
targeted in the blood.
As the blood used in these experiments was isolated by a 
simple finger-prick extraction (similar to that performed at 
home by diabetes patients) rather than intravenous extrac-
tion without any visible clot formation or other identifiable 
caveat, these data suggest that the platform is robust enough 
to be adapted to use by minimally trained personnel. Such a 
user-friendly system, which lends itself to cost-efficient 
mass manufacture, would be attractive for the development 
Table 2. Summary of data from all experiments: homogenous cell population (% fluorescence distribution).
HL60 HeLa HL60/Blood HeLa/Blood HL60/Buffy Coat HeLa/Buffy Coat
Capture 99.2 ± 1.1 1.8 ± 2.7 92.0 ± 5.9 0.6 ± 0.8 91.3 ± 6.0 7.8 ± 6.5
Waste 0.8 ± 1.1 98.2 ± 2.7 8.0 ± 5.9 99.4 ± 0.8 8.7 ± 6.0 92.2 ± 6.5
Table 3. Summary of data from all experiments: mixed cell 






Capture 85.2 ± 5.6 83.7 ± 4.3 10.9 ± 16.8
Waste 14.8 ± 5.6 16.3 ± 4.3 89.1 ± 16.8
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of a disposable diagnostic platform that identifies patients 
presenting particular cellular disease symptoms or to moni-
tor the progression of an active treatment program. Indeed, 
developing a POC system for monitoring the concentration 
of native levels of CD4-positive cells in a blood sample is a 
prime societal and commercial target for current HIV/AIDS 
programs, particularly in resource-poor regions such as 
Sub-Saharan Africa.35 Integrating the cell isolation system 
presented in this article with other emerging, on-disc cell-
counting microfluidic strategies developed would represent 
a key advance in bringing high-end lab-on-a-disc–based 
cell-counting technology to the bedside.
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